Annual Working Capital
-$4.83 M
-$3.44 M-247.59%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual working capital is -$4.83 million, with the most recent change of -$3.44 million (-247.59%) on December 31, 2023.
- During the last 3 years, VVOS annual working capital has fallen by -$17.38 million (-138.46%).
- VVOS annual working capital is now -124.37% below its all-time high of $19.82 million, reached on December 31, 2021.
Performance
VVOS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$2.27 M
+$1.06 M+88.01%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly working capital is $2.27 million, with the most recent change of +$1.06 million (+88.01%) on September 30, 2024.
- Over the past year, VVOS quarterly working capital has stayed the same.
- VVOS quarterly working capital is now -92.44% below its all-time high of $30.07 million, reached on June 30, 2021.
Performance
VVOS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
VVOS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -247.6% | 0.0% |
| 3 y3 years | -138.5% | -91.2% |
| 5 y5 years | -3215.9% | -75.9% |
VVOS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -124.4% | at low | -88.5% | +143.9% |
| 5 y | 5-year | -124.4% | +32.1% | -92.4% | +132.0% |
| alltime | all time | -124.4% | +32.1% | -92.4% | +132.0% |
Vivos Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.27 M(+88.0%) |
| Jun 2024 | - | $1.21 M(-127.1%) |
| Mar 2024 | - | -$4.46 M(-7.6%) |
| Dec 2023 | -$4.83 M(+247.6%) | -$4.83 M(-6.8%) |
| Sep 2023 | - | -$5.18 M(+67.3%) |
| Jun 2023 | - | -$3.10 M(-519.8%) |
| Mar 2023 | - | $738.00 K(-153.1%) |
| Dec 2022 | -$1.39 M | -$1.39 M(-137.2%) |
| Sep 2022 | - | $3.74 M(-57.6%) |
| Jun 2022 | - | $8.82 M(-40.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $14.75 M(-25.6%) |
| Dec 2021 | $19.82 M(+57.9%) | $19.82 M(-23.3%) |
| Sep 2021 | - | $25.84 M(-14.1%) |
| Jun 2021 | - | $30.07 M(+218.6%) |
| Mar 2021 | - | $9.44 M(-24.8%) |
| Dec 2020 | $12.55 M(-276.6%) | $12.55 M(-447.6%) |
| Sep 2020 | - | -$3.61 M(-17.3%) |
| Jun 2020 | - | -$4.37 M(-38.6%) |
| Dec 2019 | -$7.11 M(+4782.9%) | -$7.11 M |
| Dec 2018 | -$145.60 K | - |
FAQ
- What is Vivos Therapeutics annual working capital?
- What is the all time high annual working capital for Vivos Therapeutics?
- What is Vivos Therapeutics annual working capital year-on-year change?
- What is Vivos Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly working capital year-on-year change?
What is Vivos Therapeutics annual working capital?
The current annual working capital of VVOS is -$4.83 M
What is the all time high annual working capital for Vivos Therapeutics?
Vivos Therapeutics all-time high annual working capital is $19.82 M
What is Vivos Therapeutics annual working capital year-on-year change?
Over the past year, VVOS annual working capital has changed by -$3.44 M (-247.59%)
What is Vivos Therapeutics quarterly working capital?
The current quarterly working capital of VVOS is $2.27 M
What is the all time high quarterly working capital for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly working capital is $30.07 M
What is Vivos Therapeutics quarterly working capital year-on-year change?
Over the past year, VVOS quarterly working capital has changed by $0.00 (0.00%)